Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants
Condition: Healthy Volunteers Interventions: Drug: 30 mg dexlansoprazole capsules manufactured at TOB; Drug: 30 mg dexlansoprazole capsules manufactured at TPC; Drug: 60 mg dexlansoprazole capsules manufactured at TOB; Drug: 60 mg dexlansoprazole capsules manufactured at TPC Sponsor: Takeda Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2017 Category: Research Source Type: clinical trials